AT

Abhishek Tiwari

Active Director Director DIN 10584716
DIN 10584716 First appointment Apr 2024 Primary industry Business Services
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2024
Shareholding value •••• Premium profile

About Abhishek Tiwari

Data last updated:

Abhishek Tiwari is a Director at Indigrammy Pharmaceuticals Private Limited (since 2024). The company operates in Business Services. Indigrammy Pharmaceuticals Private Limited reported revenue of ₹34.2 Lakh (FY 2025).

DIN 10584716
Primary Designation Director
Industry Business Services
First Appointment 09 Apr 2024
Oldest Company Age 6 yrs
Largest company Indigrammy Pharmaceuticals Private Limited · ₹34.2 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Apr 20242020₹34.2 Lakh (FY 2025)Active

Board colleagues of Abhishek Tiwari

NameDINCompanyDesignation
Aman Mishra08927595Indigrammy Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Indigrammy Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Abhishek Tiwari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhishek Tiwari

Abhishek Tiwari currently holds 1 directorship: Indigrammy Pharmaceuticals Private Limited (Director, since 09 Apr 2024, revenue ₹34.2 Lakh (FY 2025)).

Abhishek Tiwari was first appointed on 09 Apr 2024 as Director at Indigrammy Pharmaceuticals Private Limited.

The current boards of Abhishek Tiwari's companies include Aman Mishra (Indigrammy Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available